today announced its abstract has been accepted for poster presentation at the 2025 American Association for Cancer Research (AACR) IO Conference taking place on February 23-26, 2025 at the JW ...

A key highlight of Carisma’s involvement is the poster presentation titled “Macrophages ... with hard-to-treat cancers. This year’s AACR meeting promises to be a fertile ground for ...

The poster presentation at the 2025 AACR:IO Conference marks the first comprehensive compilation of data regarding the FHAB platform, which can strengthen the company's credibility within the ...

The poster details the potential of IO170, a TGF-β peptide vaccine that showed significantly reduced tumor growth in pancreatic adenocarcinoma and prostate cancer models. The vaccine-induced ...

Sonnet BioTherapeutics Holdings, Inc. announced that its abstract has been accepted for a poster presentation at the 2025 American Association for Cancer Research (AACR) IO Conference, scheduled ...

For more information about the conference, please visit the event website. The Company's SON-080 program is a low dose of rhIL-6 in development for Chemotherapy-Induced Peripheral Neuropathy (CIPN) ...

today announced its abstract has been accepted for poster presentation at the 2025 American Association for Cancer Research (AACR) IO Conference taking place on February 23-26, 2025 at the JW Marriott ...